Hep C Treatments Save Care Costs if Administered Early

The early initiation of a pan-genotypic regimen lowers the cost of future care, report health economists who say current policies that base access to treatment on disease stage might be short-sighted.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply